Financial Knowledge & Information Portal

Novo Nordisk (NVO) Company Profile

Updated May 3, 2019
Novo Nordisk has the following business profile:
Company's Full Name:Novo Nordisk A/S
Short Name:Novo Nordisk
Trading Ticker Symbol:NVO
Primary Exchange:NYSE
Headquarter City/Country:Denmark
Primary Industry Sector:Health Care
Seconday Sub-sector:Major Pharmaceuticals
Main Business Areas: Health Care, Major Pharmaceuticals, Biotechnology, Biotech
Dividend Payments:Dividend History

Market and Trading Information for Novo Nordisk

The following details were available for trading and market data about the stock of Novo Nordisk as of writing:
Current Share Price:$47.49
Previous Year's Closing Price:$46.07
Percentage Price Change (YTD):3.08%
Market Cap:$113.36 billion
52-week Price Range:$41.23 - $52.83
Dividend Per Share:$7.83
EPS (TTM):2.46
Price-Earnings (Trailing):19.29
Price-Earnings (Forward):17.4

Company Profile and Business Description for Novo Nordisk

Novo Nordisk A/S, incorporated on November 28, 1931, is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. The Company's insulin and other pharmaceutical products are marketed and distributed through subsidiaries, distributors and independent agents with responsibility for specific geographical areas.

The Company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. The Company also offers products, such as Tresiba (insulin degludec), which is a once-daily-insulin; Xultophy (IDegLira), which is a once-daily single-injection combination of insulin degludec (Tresiba) and liraglutide (Victoza), and Ryzodeg, which is a soluble formulation of insulin degludec and insulin aspart. The Company's Prandin/NovoNorm is an oral antidiabetic drug. The Company's brands, which are in Phase III development include Semaglutide (NN9535)/Type II diabetes; Fast-acting insulin aspart (NN1218)/Type I and II diabetes; Oral semaglutide (NN9924)/Type II diabetes; N9-GP (NN7999)/Haemophilia B; N8-GP (NN7088)/Haemophilia A, and NN8640 Once-weekly human growth hormone/Growth disorder.

As of December 31, 2016, the Company marketed its products in more than 180 countries. The Company's regional structure consists of two main commercial units: North America and International Operations. The Company's North America unit consists of the United States and Canada. The Company's International Operations covers all countries except for North America and is organized in the five regions: Europe; Latin America; Africa, Asia, the Middle East and Oceania (AAMEO); Japan and Korea, and Region China. The Company's production facilities are located at various sites in Denmark, and internationally in the United States, France, China and Brazil. The Company's active pharmaceutical ingredient (API) production sites are located in Denmark and the United States.

Novo Alle

Peer / Competitor Companies of Major Pharmaceuticals Sector

Along with Novo Nordisk A/S, the following other peer (competitor) companies also exist within the same Major Pharmaceuticals - Health Care sector whose company profile and dividend history is as follows:

▶ Abbott Labs (ABT): Abbott Laboratories, incorporated on March 6, 1900, is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical ....See Detailed Company Profile  and Dividend History.

▶ AbbVie (ABBV): AbbVie Inc. (AbbVie), incorporated on April 10, 2012, is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. ....See Detailed Company Profile  and Dividend History.

▶ Abeona Therapeutics (ABEO): Abeona Therapeutics, Inc. (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., incorporated on June 22, 1989, is focused on developing and delivering gene therapy and plasma-based products for rare diseases. The Companys lead ....See Detailed Company Profile  and Dividend History.

▶ Abeona Therapeutics (ABEOW): ....See Detailed Company Profile  and Dividend History.

▶ AC Immune SA (ACIU): AC Immune Ltd is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimers and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinsons, and ....See Detailed Company Profile  and Dividend History.

▶ ACADIA Pharma (ACAD): ACADIA Pharmaceuticals Inc., incorporated on January 16, 1997, is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. The ....See Detailed Company Profile  and Dividend History.

▶ Acasti Pharma (ACST): Acasti Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing, clinically studying and marketing new pharmaceutical products to treat human cardiovascular conditions. The Company is involved ....See Detailed Company Profile  and Dividend History.

▶ AcelRx Pharma (ACRX): AcelRx Pharmaceuticals, Inc., incorporated on July 13, 2005, is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain. The Company ....See Detailed Company Profile  and Dividend History.

▶ Achaogen (AKAO): Achaogen, Inc., incorporated on November 26, 2002, is a late-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of antibacterial treatments against multi-drug resistant (MDR) gram-negative ....See Detailed Company Profile  and Dividend History.

▶ Achillion Pharma (ACHN): Achillion Pharmaceuticals, Inc., incorporated on August 5, 1998, is a biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drug therapies for infectious diseases and ....See Detailed Company Profile  and Dividend History.

▶ Aclaris Therapeutics (ACRS): Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a clinical-stage specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing differentiated drugs for the treatment of dermatological ....See Detailed Company Profile  and Dividend History.

▶ Actinium Pharma (ATNM): Actinium Pharmaceuticals, Inc. (Actinium), incorporated on March 20, 2013, is a clinical-stage biopharmaceutical company engaged in developing cancer treatments. The Company is engaged in developing therapies for diseases using its ....See Detailed Company Profile  and Dividend History.

▶ Acura Pharma (ACUR): Acura Pharmaceuticals, Inc., incorporated on April 10, 1935, is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication ....See Detailed Company Profile  and Dividend History.

▶ Adamas Pharma (ADMS): Adamas Pharmaceuticals, Inc., incorporated on November 15, 2000, is a pharmaceutical company. The Company is engaged in developing medicines to manage the daily lives of those affected by chronic neurologic ....See Detailed Company Profile  and Dividend History.

▶ Adamis Pharma (ADMP): Adamis Pharmaceuticals Corporation, incorporated on April 22, 2004, is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products ....See Detailed Company Profile  and Dividend History.

▶ Aduro Biotech (ADRO): Aduro Biotech, Inc., incorporated on May 5, 2011, is an immunotherapy company. The Company focuses on the discovery, development and commercialization of therapies that manage the treatment of various diseases, ....See Detailed Company Profile  and Dividend History.

▶ Advanced Accelerator Applications (AAAP): Advanced Accelerator Applications S.A., incorporated on March 1, 2002, is a radiopharmaceutical company. The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. MNM uses trace ....See Detailed Company Profile  and Dividend History.

▶ Advaxis (ADXS): Advaxis, Inc., incorporated on February 28, 2002, is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are ....See Detailed Company Profile  and Dividend History.

▶ Advaxis (ADXSW): ....See Detailed Company Profile  and Dividend History.

▶ Aeglea BioTherapeutics (AGLE): Aeglea BioTherapeutics, Inc., incorporated on December 16, 2013, is a biotechnology company. The Company is engaged in the development of enzyme-based therapeutics in the field of amino acid metabolism to ....See Detailed Company Profile  and Dividend History.

... See Full List of All Stocks of Major Pharmaceuticals Sector.

Stock List of Other Health Care Sub-sectors

▶ Stocks of Sector

▶ Stocks of Biotech Sector

▶ Stocks of Biotech Apparatus Sector

▶ Stocks of Biotech Diagnostics Sector

▶ Stocks of Biotech Products Sector

▶ Stocks of Biotech Research Sector

▶ Stocks of Drug Delivery Sector

▶ Stocks of Drug Development Sector

▶ Stocks of Drug Manufacturer Sector

▶ Stocks of Health Care Sector

▶ Stocks of Health Care Equipment and Services Sector

▶ Stocks of Hospital and Nursing Management Sector

▶ Stocks of Industrial Specialties Sector

▶ Stocks of Major Pharmaceuticals Sector

▶ Stocks of Medical Dental Instruments Sector

▶ Stocks of Medical Electronics Sector

▶ Stocks of Medical Nursing Services Sector

▶ Stocks of Medical Products Sector

▶ Stocks of Medical Specialities Sector

▶ Stocks of Ophthalmic Goods Sector

▶ Stocks of Other Pharmaceuticals Sector

▶ Stocks of Precision Instruments Sector

Stock List of Other Top-level Sectors

▶ Stocks of Sector

▶ Stocks of Basic Industries Sector

▶ Stocks of Basic Materials Sector

▶ Stocks of Capital Goods Sector

▶ Stocks of Communication Services Sector

▶ Stocks of Consumer Cyclical Sector

▶ Stocks of Consumer Defensive Sector

▶ Stocks of Consumer Durables Sector

▶ Stocks of Consumer Non-Durables Sector

▶ Stocks of Consumer Services Sector

▶ Stocks of Energy Sector

▶ Stocks of Finance Sector

▶ Stocks of Financial Services Sector

▶ Stocks of Health Care Sector

▶ Stocks of Industrials Sector

▶ Stocks of Miscellaneous Sector

▶ Stocks of Public Utilities Sector

▶ Stocks of Real Estate Sector

▶ Stocks of Services Sector

▶ Stocks of Technology Sector

▶ Stocks of Transportation Sector

▶ Stocks of Utilities Sector